Enteropathogenic E. Coli is a separate genus pathogenic bacteria
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Dec 6, 2006
filing date -
Sep 23, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
An assay is provided which recognizes the absence of dehydrogenase in all pathogenic bacteria and its presence in nonpathogenic (conditionally pathogenic) bacteria creating the opportunity to separate and establish enteropathogenic Escherichia (EPE) in a pathogenic genus bacteria; genus Brilmanella. A method for diagnosing maladies of the bowel based on the existence of the Brilmanella is also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully